Genetic variability in the cholecystokinin A receptor affects lipid profile and glucose tolerance in patients with polycystic ovary syndrome by Eva Drnovsek, Mojca Jensterle, Katja Goričar, Sara Redenšek, Andrej Janež, Irina Milisav, Vita Dolžan

“…Introduction Cholecystokinin (CCK) is involved in several metabolic pathways, and CCK agonists are considered as a potential novel treatment option in populations with increased metabolic risk, including polycystic ovary syndrome (PCOS). As genetic variability of cholecystokinin A and B receptor genes (CCKAR and CCKBR, respectively) may modify their biological actions, we investigated the impact of CCKAR and CCKBR genetic variability on anthropometric and metabolic parameters in patients with PCOS. …”
Get full text

Association of insulin resistance surrogates with live birth outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization by Shenghao Wu, Yanhong Wu, Lizi Fang, Xiaosheng Lu

Subjects: “…Polycystic ovary syndrome…”
Get full text

Comparing Assisted Reproductive Outcomes in Women with Different Polycystic Ovary Syndrome Phenotypes Undergoing Frozen Embryo Transfer by Anubhuti Patel, Anviti Saraf, Vyshnavi A. Rao, Kamini A. Rao

“…Aims: To assess the outcomes of assisted reproductive technology (ART) in various polycystic ovary syndrome (PCOS) phenotypes and to evaluate the predictive value of anti-Mullerian hormone (AMH) and total testosterone on ART success. …”
Get full text

Diagnostic Utility of Various Hormones across Different Polycystic Ovary Syndrome Phenotypes: A Cross-sectional Study by Padala Ravi Kumar, Radha Krishna Telagareddy, Deepak Kumar Dash, Debasish Patro

Subjects: Get full text

Treatment with Metformin Can Improve Insulin Resistance and Lipid Profile in Non-Diabetic Iraqi Women with Polycystic Ovary Syndrome by Ali M. Kadim Al-Tuma, Saba Sabeeh Hussain, Muhjah Falah Hassan

“…Background: Women with polycystic ovary syndrome (PCOS) are usually at increased risk of metabolic syndrome and insulin resistance (IR), regardless of their body weight, and the development of type 2 diabetes in those women is not uncommon. …”
Get full text

Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation by Katarzyna Wyskida, Grzegorz Franik, Piotr Choręza, Natalia Pohl, Leszek Markuszewski, Aleksander Owczarek, Paweł Madej, Jerzy Chudek, Magdalena Olszanecka-Glinianowicz

Get full text

Oxidative Stress in Endometrial Flushing Fluid of Patients with Polycystic Ovary Syndrome, Endometrioma and Uterine Leiomyoma: Comparison with Healthy Controls by Mustafa Demir, Onur Ince, Bulent Yilmaz, Mert Ulas Barut, Ulviye Cansu Ozturk, Avni Kılıc, Ahmet Berkiz Turp, Recep Sutcu, Seyithan Taysi

Subjects: Get full text

Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls by Justyna Kuliczkowska Plaksej, Lukasz Laczmanski, Andrzej Milewicz, A. Lenarcik-Kabza, Anna Trzmiel-Bira, Urszula Zaleska-Dorobisz, Felicja Lwow, Lidia Hirnle

“…Context. Polycystic ovary syndrome (PCOS) is frequently associated with nonalcoholic fatty liver disease (NAFLD). …”
Get full text

Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome by Susanne Tan, Nils Vollmar, Sven Benson, Jan-Peter Sowa, Lars P. Bechmann, Guido Gerken, Dagmar Fuhrer, Ali Canbay

“…Objective. Polycystic ovary syndrome (PCOS) is associated with obesity and insulin resistance (IR), key features of nonalcoholic steatohepatitis (NASH). …”
Get full text

Evaluation of Predictors of Response to Ovulation Induction Using Letrozole in Women with Polycystic Ovary Syndrome: A Prospective Cohort Study by Shanti Tholiya, Archana Kumari, Reeta Mahey, Mani Kalaivani, Hem Chandra Sati, Mona Sharma, Aarthi K. Jayraj, Neena Malhotra

Subjects: Get full text

Perceived Effects and Prevention of Polycystic Ovary Syndrome among Women Living in Ilorin-South LGA, Kwara State, Nigeria by Abdulqudus Tosin Jamiu, Kamalud-deen Adekunle Uthman, Tawakalitu Kikelomo Ijaodola, Khadijah Morenikeji Mutairu, Opeyemi Funke Obaditan

“…Results: The study revealed that obesity (ᵪ2 =42.837) and infertility (ᵪ2 =76.729) are significant perceived effects of polycystic ovary syndrome and healthy diet (ᵪ2 =39.442) is a significant perceived prevention of polycystic ovary syndrome @ 0.05 alpha level. …”
Get full text

Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets by Xuedan Lai, Ling Wu, Peihong Lin, Lijiao You, Jianwen Ye

Subjects: Get full text

Whole transcriptome analysis and construction of gene regulatory networks of granulosa cells from patients with polycystic ovary syndrome (PCOS) by Yuan Yuan, Daiterigele, Qian Zhang, Chen Du

Subjects: Get full text

Distinct mechanisms of electroacupuncture and manual acupuncture in modulating hypothalamic GnRH–tanycyte unit function of polycystic ovary syndrome by Yu Wang, Yicong Wang, Yuning Chen, Wenhan Lu, Xiaoyu Tong, Jiajia Li, Wenhao Gao, Rui Huang, Wei Hu, Yi Feng

Subjects: “…Polycystic ovary syndrome…”
Get full text

The role of diet and physical activity in PCOS - A Quick Review by Natalia Pawelec, Weronika Mazur, Artur Hawajski, Natalia Jankowska, Adrianna Świerzyńska, Alicja Kapciak, Julia Górny, Katarzyna Naja

Subjects: “…polycystic ovary syndrome…”
Get full text

The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials by Hong Gao, YanTao Li, WenNan Yan, Fei Gao

“…Studies have found that vitamin D supplementation may improve blood lipids in patients with polycystic ovary syndrome, but the results are controversial, so this study will further analyze the effect of vitamin D supplementation on blood lipids in patients with polycystic ovary syndrome. …”
Get full text

Virtual screening and molecular docking of Indonesian phytoconstituents as potential inhibitors of peroxisome proliferator-activated receptor gamma in polycystic ovary syndrome by Tunjungseto Arif, Iffatunnisa Fakhriyah, Pratiwi Intan Winta, Alif Azzam Muhyiddin Afrizal, Ahsan Fadhil, Santoso Budi

“…Polycystic ovary syndrome (PCOS) is the most common endocrinology disorder affecting women of reproductive age, characterized by irregular menstruation, androgen overproduction and insulin resistance. …”
Get full text

Relationship between CCL25/CCR9 Levels in Follicular Fluid and High Ovarian Response in Patients with Polycystic Ovary Syndrome by Yongxin Hao, Qianqian Yin, Fangfang Hu, Xiaoyan Liu, Yaru Yang, Fang Sun, Xiaonan Yan

“…Objective. Polycystic ovary syndrome (PCOS) is one of the prevalent gynecological endocrine disorders encountered in clinical practice. …”
Get full text

Effects of non-pharmacological interventions on biochemical hyperandrogenism in women with polycystic ovary syndrome: a systematic review and network meta-analysis by Qi Jin, Ge Xu, Yuchen Ying, Lumin Liu, Huimin Zheng, Shifen Xu, Ping Yin, Yuelai Chen

Subjects: “…Polycystic ovary syndrome…”
Get full text

Serum Concentrations of Betatrophin and Its Association with Indirect Indices of Insulin Resistance and Beta Cell Function in Women with Polycystic Ovary Syndrome by Agnieszka Adamska, Agnieszka Łebkowska, Małgorzata Jacewicz, Anna Krentowska, Justyna Hryniewicka, Sławomir Wołczyński, Maria Górska, Irina Kowalska

“…Data underline the role of betatrophin in glucose homeostasis. Polycystic ovary syndrome (PCOS) is characterized by insulin resistance (IR). …”
Get full text